Login to Your Account



New deal a win-win for Sun Pharma and Samsung Biologics

By Haky Moon
Staff Writer

Thursday, July 6, 2017

HONG KONG – Facing increased U.S. regulatory scrutiny, Sun Pharmaceutical Industries Ltd. is outsourcing some of its manufacturing in a deal that provides Samsung Biologics Co. Ltd. an opportunity to expand its market share.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription